The EverestIMS Technologies IPO is a closed SME Bookbuilding offer (Fresh capital cum OFS) that opened on 29 September 2026. The EverestIMS Technologies IPO closed on 5 October 2026, with an issue price of ₹85 per share. The EverestIMS Technologies IPO has a face value of ₹10 and a lot size of 1,600 shares. The EverestIMS Technologies IPO size aggregates up to ₹48 crore, listing on BSE SME on 8 October 2026. The EverestIMS Technologies IPO allotment was scheduled for 6 October 2026.
On the financial front, the EverestIMS Technologies IPO reported revenue of ₹66 crore for 31 Mar 2026, compared with ₹58 crore for 31 Mar 2025. The EverestIMS Technologies IPO PAT was ₹13 crore against ₹14 crore. The EverestIMS Technologies IPO EBITDA stood at ₹23 crore with a 23.66% margin. The EverestIMS Technologies IPO net worth as of 31 Mar 2026 was ₹61 crore.
Always verify The EverestIMS Technologies IPO details and GMP data with the official offer document before investing in the EverestIMS Technologies IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
90
68
50
Revenue
66
58
46
PAT
13
14
11
EBITDA
23
23
17
Net Worth
61
47
32
Reserves
44
30
30
EverestIMS Technologies IPO Financials FAQs
Revenue of EverestIMS Technologies (Amount in ₹ Crore) — 31 Mar 2026: 66; 31 Mar 2025: 58; 31 Mar 2024: 46. Profit after tax (PAT) — 31 Mar 2026: 13; 31 Mar 2025: 14; 31 Mar 2024: 11.
EBITDA of EverestIMS Technologies (Amount in ₹ Crore) — 31 Mar 2026: 23; 31 Mar 2025: 23; 31 Mar 2024: 17. The EBITDA margin is 23.66%.
Total assets — 31 Mar 2026: 90; 31 Mar 2025: 68; 31 Mar 2024: 50. Net worth — 31 Mar 2026: 61; 31 Mar 2025: 47; 31 Mar 2024: 32. Reserves & surplus — 31 Mar 2026: 44; 31 Mar 2025: 30; 31 Mar 2024: 30. (Amount in ₹ Crore)
The financials shown for EverestIMS Technologies IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
